Evidence map›Paper›PMID 39744192›Full record

ArticleWorld journal of hepatology2024

Evaluation of autoimmune phenomena in patients with nonalcoholic fatty liver disease on the basis of liver pathology.

Yu-Jin Zhu, Yan Zhang, Yao Rao, Yong Jiang, Yong-Gang Liu, Jian-Zhou Li, Jia-Qi Yuan, Ying Zhao, Wen-Wen Zheng, Lin Ma and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in World journal of hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu-Jin ZhuDepartment of Infectious Diseases, Xi'an No. 3 Hospital, the Affiliated Hospital of Northwest University, Xi'an 710018, Shaanxi Province, China.
Yan ZhangDepartment of Epidemiology, Tianjin Medical University, Tianjin 300070, China.
Yao RaoDepartment of Gastroenterology, Clinical School of the Second People's Hospital, Tianjin 300110, China.
Yong JiangDepartment of Gastroenterology, The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
Yong-Gang LiuDepartment of Pathology, Clinical School of the Second People's Hospital, Tianjin 300110, China.
Jian-Zhou LiDepartment of Gastro-Enterologie, Xining Second People's Hospital, Xining 810003, Qinghai Province, China.
Jia-Qi YuanDepartment of Gastro-Enterologie, Xining Second People's Hospital, Xining 810003, Qinghai Province, China.
Ying ZhaoDepartment of Epidemiology, Tianjin Medical University, Tianjin 300070, China.
Wen-Wen ZhengDepartment of Epidemiology, Tianjin Medical University, Tianjin 300070, China.
Lin MaDepartment of Epidemiology, Tianjin Medical University, Tianjin 300070, China.
Chun-Yan WangDepartment of Gastroenterology, Clinical School of the Second People's Hospital, Tianjin 300110, China. wangchunyan123@tmu.edu.cn.
Jia LiDepartment of Gastroenterology, Clinical School of the Second People's Hospital, Tianjin 300110, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutoimmune phenomena can be used in some patients with nonalcoholic fatty liver disease (NAFLD) in the clinic, but these patients are not autoimmune hepatitis patients.

aimTo determine whether autoimmunity is present in patients with NAFLD, this study was performed.

methodsA total of 104 patients with NAFLD diagnosed by liver biopsy at Tianjin Second People's Hospital between 2019 and 2023 were enrolled. The patients were divided into three groups according to their biopsy results: The NAFL (

resultsThe differences in IgA, an immune marker, among the three groups of patients were statistically significant (

conclusionAutoimmune phenomena occur in NAFLD patients, especially in patients with NAFLD-related cirrhosis, in whom this phenomenon may be more pronounced.

Indexed as

AutoantibodyAutoimmunityClinical indicatorLiver pathologyNonalcoholic fatty liver disease

Identifiers

PMID39744192
PMCPMC11686539

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.